Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Type

Guidance programme

Showing 1 to 5 of 5

TitleReference numberPublishedLast updated
Zanubrutinib for treating relapsed or refractory mantle cell lymphomaTA1081
Zanubrutinib for treating marginal zone lymphoma after anti-CD20-based treatmentTA1001
Zanubrutinib with obinutuzumab for treating relapsed or refractory B-cell follicular lymphoma after 2 or more treatments (terminated appraisal)TA978
Zanubrutinib for treating chronic lymphocytic leukaemiaTA931
Zanubrutinib for treating Waldenstrom's macroglobulinaemiaTA833

Results per page

  1. 10
  2. 25
  3. 50
  4. All